Literature DB >> 9880324

Different tyrosine autophosphorylation requirements in fibroblast growth factor receptor-1 mediate urokinase-type plasminogen activator induction and mitogenesis.

P Dell'Era1, M Mohammadi, M Presta.   

Abstract

Among the seven tyrosine autophosphorylation sites identified in the intracellular domain of tyrosine kinase fibroblast growth factor receptor-1 (FGFR1), five of them are dispensable for FGFR1-mediated mitogenic signaling. The possibility of dissociating the mitogenic activity of basic FGF (FGF2) from its urokinase-type plasminogen activator (uPA)-inducing capacity both at pharmacological and structural levels prompted us to evaluate the role of these autophosphorylation sites in transducing FGF2-mediated uPA upregulation. To this purpose, L6 myoblasts transfected with either wild-type (wt) or various FGFR1 mutants were evaluated for the capacity to upregulate uPA production by FGF2. uPA was induced in cells transfected with wt-FGFR1, FGFR1-Y463F, -Y585F, -Y730F, -Y766F, or -Y583/585F mutants. In contrast, uPA upregulation was prevented in L6 cells transfected with FGFR1-Y463/583/585/730F mutant (FGFR1-4F) or with FGFR1-Y463/583/585/730/766F mutant (FGFR1-5F) that retained instead a full mitogenic response to FGF2; however, preservation of residue Y730 in FGFR1-Y463/583/585F mutant (FGFR1-3F) and FGFR1-Y463/583/585/766F mutant (FGFR1-4Fbis) allows the receptor to transduce uPA upregulation. Wild-type FGFR1, FGFR1-3F, and FGFR1-4F similarly bind to a 90-kDa tyrosine-phosphorylated protein and activate Shc, extracellular signal-regulated kinase (ERK)2, and JunD after stimulation with FGF2. These data, together with the capacity of the ERK kinase inhibitor PD 098059 to prevent ERK2 activation and uPA upregulation in wt-FGFR1 cells, suggest that signaling through the Ras/Raf-1/ERK kinase/ERK/JunD pathway is necessary but not sufficient for uPA induction in L6 transfectants. Accordingly, FGF2 was able to stimulate ERK1/2 phosphorylation and cell proliferation, but not uPA upregulation, in L6 cells transfected with the FGFR1-Y463/730F mutant, whereas the FGFR1-Y583/585/730F mutant was fully active. We conclude that different tyrosine autophosphorylation requirements in FGFR1 mediate cell proliferation and uPA upregulation induced by FGF2 in L6 cells. In particular, phosphorylation of either Y463 or Y730, dispensable for mitogenic signaling, represents an absolute requirement for FGF2-mediated uPA induction.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 9880324      PMCID: PMC25151          DOI: 10.1091/mbc.10.1.23

Source DB:  PubMed          Journal:  Mol Biol Cell        ISSN: 1059-1524            Impact factor:   4.138


  58 in total

Review 1.  Protein modules and signalling networks.

Authors:  T Pawson
Journal:  Nature       Date:  1995-02-16       Impact factor: 49.962

2.  Novel recognition motif on fibroblast growth factor receptor mediates direct association and activation of SNT adapter proteins.

Authors:  H Xu; K W Lee; M Goldfarb
Journal:  J Biol Chem       Date:  1998-07-17       Impact factor: 5.157

3.  Broadly expressed SNT-like proteins link FGF receptor stimulation to activators of Ras.

Authors:  J K Wang; H Xu; H C Li; M Goldfarb
Journal:  Oncogene       Date:  1996-08-15       Impact factor: 9.867

4.  The expression and localization of urokinase-type plasminogen activator and its type 1 inhibitor are regulated by retinoic acid and fibroblast growth factor in human teratocarcinoma cells.

Authors:  J Tienari; T Alanko; E Lehtonen; O Saksela
Journal:  Cell Regul       Date:  1991-04

5.  A tyrosine-phosphorylated carboxy-terminal peptide of the fibroblast growth factor receptor (Flg) is a binding site for the SH2 domain of phospholipase C-gamma 1.

Authors:  M Mohammadi; A M Honegger; D Rotin; R Fischer; F Bellot; W Li; C A Dionne; M Jaye; M Rubinstein; J Schlessinger
Journal:  Mol Cell Biol       Date:  1991-10       Impact factor: 4.272

6.  Structure-function relationship of basic fibroblast growth factor: site-directed mutagenesis of a putative heparin-binding and receptor-binding region.

Authors:  M Presta; M Statuto; A Isacchi; P Caccia; A Pozzi; A Gualandris; M Rusnati; L Bergonzoni; P Sarmientos
Journal:  Biochem Biophys Res Commun       Date:  1992-06-30       Impact factor: 3.575

7.  Fibroblast growth factor receptor (FGFR) 3. Alternative splicing in immunoglobulin-like domain III creates a receptor highly specific for acidic FGF/FGF-1.

Authors:  A T Chellaiah; D G McEwen; S Werner; J Xu; D M Ornitz
Journal:  J Biol Chem       Date:  1994-04-15       Impact factor: 5.157

8.  Reduced activation of RAF-1 and MAP kinase by a fibroblast growth factor receptor mutant deficient in stimulation of phosphatidylinositol hydrolysis.

Authors:  J Huang; M Mohammadi; G A Rodrigues; J Schlessinger
Journal:  J Biol Chem       Date:  1995-03-10       Impact factor: 5.157

9.  A region in Shc distinct from the SH2 domain can bind tyrosine-phosphorylated growth factor receptors.

Authors:  P Blaikie; D Immanuel; J Wu; N Li; V Yajnik; B Margolis
Journal:  J Biol Chem       Date:  1994-12-23       Impact factor: 5.157

10.  FGFR-4, a novel acidic fibroblast growth factor receptor with a distinct expression pattern.

Authors:  J Partanen; T P Mäkelä; E Eerola; J Korhonen; H Hirvonen; L Claesson-Welsh; K Alitalo
Journal:  EMBO J       Date:  1991-06       Impact factor: 11.598

View more
  8 in total

1.  Fibronectin induces endothelial cell migration through β1 integrin and Src-dependent phosphorylation of fibroblast growth factor receptor-1 at tyrosines 653/654 and 766.

Authors:  Li Zou; Sheng Cao; Ningling Kang; Robert C Huebert; Vijay H Shah
Journal:  J Biol Chem       Date:  2012-01-14       Impact factor: 5.157

2.  Identification of tyrosine residues in constitutively activated fibroblast growth factor receptor 3 involved in mitogenesis, Stat activation, and phosphatidylinositol 3-kinase activation.

Authors:  K C Hart; S C Robertson; D J Donoghue
Journal:  Mol Biol Cell       Date:  2001-04       Impact factor: 4.138

3.  Immunochemical expression of fibroblast growth factor and its receptors in primary tumor cells of renal cell carcinoma.

Authors:  Maria Volkova; Ilya Tsimafeyeu; Anna Olshanskaya; Yulia Khochenkova; Eliso Solomko; Saida Ashuba; Vsevolod Matveev; Dmitry Khochenkov
Journal:  Am J Clin Exp Urol       Date:  2021-02-15

4.  Regulation and substrate specificity of the SR protein kinase Clk/Sty.

Authors:  Jayendra Prasad; James L Manley
Journal:  Mol Cell Biol       Date:  2003-06       Impact factor: 4.272

5.  Structural and functional basis of a role for CRKL in a fibroblast growth factor 8-induced feed-forward loop.

Authors:  Ji-Heui Seo; Atsushi Suenaga; Mariko Hatakeyama; Makoto Taiji; Akira Imamoto
Journal:  Mol Cell Biol       Date:  2009-03-23       Impact factor: 4.272

Review 6.  Tumor Microenvironment in Prostate Cancer: Toward Identification of Novel Molecular Biomarkers for Diagnosis, Prognosis, and Therapy Development.

Authors:  Hisham F Bahmad; Mohammad Jalloul; Joseph Azar; Maya M Moubarak; Tamara Abdul Samad; Deborah Mukherji; Mohamed Al-Sayegh; Wassim Abou-Kheir
Journal:  Front Genet       Date:  2021-03-26       Impact factor: 4.599

7.  Fibroblast growth factor receptor-1 phosphorylation requirement for cardiomyocyte differentiation in murine embryonic stem cells.

Authors:  Roberto Ronca; Laura Gualandi; Elisabetta Crescini; Stefano Calza; Marco Presta; Patrizia Dell'Era
Journal:  J Cell Mol Med       Date:  2009-06-22       Impact factor: 5.310

Review 8.  Molecular and clinical significance of fibroblast growth factor 2 (FGF2 /bFGF) in malignancies of solid and hematological cancers for personalized therapies.

Authors:  Mohamed R Akl; Poonam Nagpal; Nehad M Ayoub; Betty Tai; Sathyen A Prabhu; Catherine M Capac; Matthew Gliksman; Andre Goy; K Stephen Suh
Journal:  Oncotarget       Date:  2016-07-12
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.